Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 55171-55172 [2018-23976]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 213 / Friday, November 2, 2018 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, limited only by
the space available. The meeting space
accommodates approximately 150
people and the audio conference line
has 150 ports for callers. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
teleconference (information below).
DATES: The meeting will be held on
December 12, 2018 from 8:30 a.m. to
5:30 p.m., PST, and December 13, 2018,
8:15 a.m. to 2:30 p.m., PST. A public
comment session will be held on
December 12, 2018 at 5:30 p.m. and
conclude at 6:30 p.m. or following the
final call for public comment,
whichever comes first.
ADDRESSES: Crowne Plaza, 300 North
Harbor Drive, Redondo Beach,
California 90272; Phone: (310) 318–
8888, Fax: (310) 376–1930 and audio
conference call via FTS Conferencing.
The USA toll-free dial-in number is 1–
866–659–0537; the pass code is
9933701. Web conference by Skype:
Meeting CONNECTION: https://
webconf.cdc.gov/zab6/yzdq02pl?sl=1.
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta,
Georgia 30329, Telephone (513) 533–
6800, Toll Free 1 (800) CDC–INFO,
Email ocas@cdc.gov. .
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
SUMMARY:
VerDate Sep<11>2014
17:57 Nov 01, 2018
Jkt 247001
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The Advisory Board’s charter was
issued on August 3, 2001, renewed at
appropriate intervals, rechartered under
Executive Order 13811 on February 12,
2018, and will terminate on September
30, 2019.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to be Considered: The agenda
will include discussions on the
following: NIOSH Program Update;
Department of Labor Program Update;
Department of Energy Program Update;
SEC Petitions Update; possible
discussion of a site profile review (dose
reconstruction methods) for
Carborundum Company (Niagara Falls,
New York); SEC Petitions for: Y–12
Plant (Oak Ridge, Tennessee), Metals
and Controls Corporation (Attleboro,
Massachusetts, Area IV Santa Susanna
Field Laboratory (Ventura County,
California), DeSoto Avenue Facility (Los
Angeles, California), Superior Steel
Company (Carnegie, Pennsylvania), and
Los Alamos National Laboratory (Los
Alamos, New Mexico); and a Board
Work Session. Agenda items are subject
to change as priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
55171
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–23975 Filed 11–1–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention Board of Scientific
Counselors, National Center for Injury
Prevention and Control, (BSC, NCIPC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC). This
meeting is open to the public limited
only by the space and ports available.
The meeting room accommodates 70
participants and there will be 75 ports
available. Due to the limited availability
of phone line ports, we are encouraging
the pubic to please register using the
link provided: Register Here. There will
be a public comment period at the end
of the day from 03:30 p.m.—04:00 p.m.
DATES: The meeting will be held on
December 12, 2018, 09:00 a.m. to 04:30
p.m., EST.
ADDRESSES: Center for Disease Control
and Prevention, Chamblee Campus,
Building 106, Conference Room 1–A,
4770 Buford Highway, Atlanta, Georgia
30341 and via Teleconference: Dial-In
Number: 1–888–780–9652, Participant
Code: 8435823.
FOR FURTHER INFORMATION CONTACT:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway, NE, Mailstop F–63, Atlanta,
GA 30341, Telephone (770) 488–1430.
Email address: ncipcbsc@cdc.gov
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
SUMMARY:
E:\FR\FM\02NON1.SGM
02NON1
55172
Federal Register / Vol. 83, No. 213 / Friday, November 2, 2018 / Notices
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
Board of Scientific Counselors makes
recommendations regarding policies,
strategies, objectives, and priorities; and
reviews progress toward injury
prevention goals and provides evidence
in injury prevention-related research
and programs. The Board also provides
advice on the appropriate balance of
intramural and extramural research, the
structure, progress and performance of
intramural programs. The Board is
designed to provide guidance on
extramural scientific program matters,
including the: (1) Review of extramural
research concepts for funding
opportunity announcements; (2)
conduct of Secondary Peer Review of
extramural research grants, cooperative
agreements, and contracts applications
received in response to the funding
opportunity announcements as it relates
to the Center’s programmatic balance
and mission; (3) submission of
secondary review recommendations to
the Center Director of applications to be
considered for funding support; (4)
review of research portfolios, and (5)
review of program proposals.
Matters to be Considered: The Board
of Scientific Counselors will discuss
science matters to include research
strategies needed to guide the Center’s
focus on reducing opioid overdose and
to review the recommendations from the
opioid prescribing for acute and chronic
pain workgroup. Agenda items are
subject to change as priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–23976 Filed 11–1–18; 8:45 am]
BILLING CODE 4163–19–P
VerDate Sep<11>2014
17:57 Nov 01, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Council for the
Elimination of Tuberculosis Meeting
(ACET). This meeting is open to the
public, limited only by the space
available. The meeting room
accommodates approximately 80 people
and has 100 ports for audio phone lines.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt is Monday,
December 10, 2018. Persons who desire
to make an oral statement, may request
it at the time of the public comment
period on December 12, 2018 at 11:40
a.m., EST.
DATES: The meeting will be held on
December 11, 2018, 8:30 a.m. to 4:30
p.m., EST and December 12, 2018, 8:30
a.m. to 12:00 p.m., EST.
ADDRESSES: 8 Corporate Blvd., Building
8, Conference Rooms 1–A/B/C, Atlanta,
Georgia, 30329 and Web conference: 1–
877–927–1433 and participant
passcode: 12016435 and https://
adobeconnect.cdc.gov/r5p8l2tytpq/.
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600
Clifton Road, NE, Mailstop: E–07,
Atlanta, Georgia, 30333, telephone (404)
639–8317; zkr7@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This Council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis.
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters to be Considered: The agenda
will include discussions on (1) Division
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
of Tuberculosis Elimination (DTBE)
funded Demonstration Project on Latent
Tuberculosis Infection (LTBI) Testing
and Treatment; (2) DTBE
Communications Messaging and
Campaigns; (3) Update on LTBI
Treatment Guidelines; (4) Update on
Drug Resistant Tuberculosis Guidelines;
and (5) Update from ACET workgroups.
Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–23974 Filed 11–1–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3371–PN]
Medicare and Medicaid Programs:
Accreditation Commission for Health
Care, Inc (ACHC) for Approval of its
End Stage Renal Disease (ESRD)
Facility Accreditation Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice with request for
comment.
AGENCY:
This proposed notice
acknowledges the receipt of an
application from the Accreditation
Commission for Health Care, Inc., for
recognition as a national accrediting
organization for End Stage Renal
Disease Facilities that wish to
participate in the Medicare or Medicaid
programs.
DATES: To be assured consideration,
comments must be received at one of
the addresses provided below, no later
than 5 p.m. on December 3, 2018.
ADDRESSES: In commenting, refer to file
code CMS–3371–PN. Because of staff
and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
Comments, including mass comment
submissions, must be submitted in one
of the following three ways (please
choose only one of the ways listed):
SUMMARY:
E:\FR\FM\02NON1.SGM
02NON1
]]>Agencies
[Federal Register Volume 83, Number 213 (Friday, November 2, 2018)]
[Notices]
[Pages 55171-55172]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23976]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Board of Scientific
Counselors, National Center for Injury Prevention and Control, (BSC,
NCIPC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control, (BSC, NCIPC). This
meeting is open to the public limited only by the space and ports
available. The meeting room accommodates 70 participants and there will
be 75 ports available. Due to the limited availability of phone line
ports, we are encouraging the pubic to please register using the link
provided: Register Here. There will be a public comment period at the
end of the day from 03:30 p.m.--04:00 p.m.
DATES: The meeting will be held on December 12, 2018, 09:00 a.m. to
04:30 p.m., EST.
ADDRESSES: Center for Disease Control and Prevention, Chamblee Campus,
Building 106, Conference Room 1-A, 4770 Buford Highway, Atlanta,
Georgia 30341 and via Teleconference: Dial-In Number: 1-888-780-9652,
Participant Code: 8435823.
FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway, NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770)
488-1430. Email address: [email protected]
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
[[Page 55172]]
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The Board of Scientific
Counselors makes recommendations regarding policies, strategies,
objectives, and priorities; and reviews progress toward injury
prevention goals and provides evidence in injury prevention-related
research and programs. The Board also provides advice on the
appropriate balance of intramural and extramural research, the
structure, progress and performance of intramural programs. The Board
is designed to provide guidance on extramural scientific program
matters, including the: (1) Review of extramural research concepts for
funding opportunity announcements; (2) conduct of Secondary Peer Review
of extramural research grants, cooperative agreements, and contracts
applications received in response to the funding opportunity
announcements as it relates to the Center's programmatic balance and
mission; (3) submission of secondary review recommendations to the
Center Director of applications to be considered for funding support;
(4) review of research portfolios, and (5) review of program proposals.
Matters to be Considered: The Board of Scientific Counselors will
discuss science matters to include research strategies needed to guide
the Center's focus on reducing opioid overdose and to review the
recommendations from the opioid prescribing for acute and chronic pain
workgroup. Agenda items are subject to change as priorities dictate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-23976 Filed 11-1-18; 8:45 am]
BILLING CODE 4163-19-P
